person · Reporting owner

Turner Nathaniel S.

Disclosed activity across 2 companies

Tapewire entity: 64884
SEC CIK: 0001838734

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419	Director	January 07, 2021	February 23, 2022
MOZAYYX Acquisition Corp.MZYX · Entity 5716	Director	February 24, 2026	February 24, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report date January 07, 2021 · Filed February 23, 2022 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table II · derivative / convertible security	IndirectHeld by Multiple Holdings, LLC	1,324,728	Reported balance After 2021-01-07 transaction · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · 2021-01-07 · Grant · Acquired 1,324,728 · Balance 1,324,728 F1: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F2: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 686,782 shares of common stock of Legacy Clover. F3: The Reporting Person is a partner in Multiple Holdings, LLC and may be deemed to share voting power and dispositive power over 1,324,728 shares held by Multiple Holdings, LLC. Excludes 1,241,226 shares held by Multiple Holdings LLC, as to which, in accordance with the terms of the operating agreement of that entity, Mr. Turner does not have voting or dispositive power over such shares, nor any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation.

F2: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 686,782 shares of common stock of Legacy Clover.

F3: The Reporting Person is a partner in Multiple Holdings, LLC and may be deemed to share voting power and dispositive power over 1,324,728 shares held by Multiple Holdings, LLC. Excludes 1,241,226 shares held by Multiple Holdings LLC, as to which, in accordance with the terms of the operating agreement of that entity, Mr. Turner does not have voting or dispositive power over such shares, nor any pecuniary interest therein.

MOZAYYX Acquisition Corp.

Report date February 24, 2026 · Filed February 24, 2026

This filing explicitly reported no securities owned.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 01, 2021 Filed Apr 6, 2021 01:36 UTC	CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419	GrantRestricted Stock Unit · Derivative	38,392	$0.00	$0.00	Disclosure SEC source: 0001209191-21-025544 · doc4.xml · derivative · entry 1 Turner Nathaniel S. · CIK 0001838734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,392 Underlying: Class A Common Stock · 38,392 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Turner's continued service as a member of the Board through such vesting date. F2 · derivative.expiration_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Turner's continued service as a member of the Board through such vesting date. Read SEC document
January 07, 2021 Filed Jan 12, 2021 02:17 UTC	CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419	GrantClass B Common Stock · Derivative	2,565,954	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-003166 · doc4.xml · derivative · entry 1 Turner Nathaniel S. · CIK 0001838734 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Multiple Holdings, LLC Disclosed balance after: 2,565,954 Underlying: Class A Common Stock · 2,565,954 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F2 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 1,330,273 shares of common stock of Legacy Clover. F1 · derivative.exercise_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F3 · ownership.nature: The Reporting Person is a partner in Multiple Holdings, LLC and may be deemed to share voting power and dispositive power over the shares held by Multiple Holdings, LLC. Read SEC document
January 07, 2021 Filed Feb 23, 2022 02:51 UTC Amendment	CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419	GrantClass B Common Stock · Derivative	1,324,728	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-22-003422 · wf-form4a_164558468587234.xml · derivative · entry 1 Turner Nathaniel S. · CIK 0001838734 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Multiple Holdings, LLC Disclosed balance after: 1,324,728 Underlying: Class A Common Stock · 1,324,728 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F2 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 686,782 shares of common stock of Legacy Clover. F1 · derivative.exercise_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. F3 · ownership.nature: The Reporting Person is a partner in Multiple Holdings, LLC and may be deemed to share voting power and dispositive power over 1,324,728 shares held by Multiple Holdings, LLC. Excludes 1,241,226 shares held by Multiple Holdings LLC, as to which, in accordance with the terms of the operating agreement of that entity, Mr. Turner does not have voting or dispositive power over such shares, nor any pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.